4.7 Review

Orellanine: From Fungal Origin to a Potential Future Cancer Treatment

Related references

Note: Only part of the references are listed.
Article Chemistry, Analytical

Determination of Orellanine in Human Biological Matrices Using Liquid Chromatography with High-Resolution Mass Spectrometry Detection: A Validated Method Applied to Suspected Poisoning Cases

Estelle Flament et al.

Summary: The detection and quantification of orellanine in biological samples is crucial for the diagnosis and management of suspected cases of mushroom poisoning.

JOURNAL OF ANALYTICAL TOXICOLOGY (2023)

Article Pharmacology & Pharmacy

Mirvetuximab Soravtansine: First Approval

Young-A Heo

DRUGS (2023)

Review Biochemistry & Molecular Biology

Antibody drug conjugate: the biological missile for targeted cancer therapy

Zhiwen Fu et al.

Summary: Antibody-drug conjugates (ADCs) combine the highly specific targeting ability of monoclonal antibodies with the potent killing effect of cytotoxic drugs to accurately and efficiently eliminate cancer cells. Since the approval of the first ADC in 2000, 14 ADCs have been marketed worldwide, with over 100 ADC candidates currently in clinical trials. These novel cancer therapeutics, known as biological missiles, are leading the way in targeted cancer therapy.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Oncology

Identification of a Synthetic Lethal Relationship between Nucleotide Excision Repair Deficiency and Irofulven Sensitivity in Urothelial Cancer

Judit Borcsok et al.

Summary: The study revealed a synthetic lethal relationship between tumor NER deficiency and sensitivity to irofulven. In addition, a composite mutational signature of ERCC2 deficiency was strongly associated with cisplatin and irofulven sensitivity, showing potential for identifying patients likely to respond to NER-targeting agents.

CLINICAL CANCER RESEARCH (2021)

Article Oncology

Patterns of distant metastases in patients with clear cell renal cell carcinoma--A population-based analysis

Jianxin Xue et al.

Summary: This study aimed to describe distant metastasis patterns in ccRCC patients, with the lung being the most common metastatic site. Different survival outcomes and prognostic factors were identified for different metastatic patterns. This research would be valuable for future clinical practice.

CANCER MEDICINE (2021)

Review Pharmacology & Pharmacy

Antibody-drug conjugates: Recent advances in linker chemistry

Zheng Su et al.

Summary: ADCs are gradually revolutionizing clinical cancer therapy, and the linker molecule plays a crucial role in determining their efficacy and safety. An ideal linker should release the cytotoxic payload specifically in the tumor to avoid off-target toxicity. Recent research progress in novel linkers for ADCs has been significant, aiming to improve therapeutic outcomes and minimize adverse effects.

ACTA PHARMACEUTICA SINICA B (2021)

Review Food Science & Technology

Toxic Effects of Amanitins: Repurposing Toxicities toward New Therapeutics

Brendan Le Dare et al.

Summary: The consumption of mushrooms, particularly those with medicinal properties, has led to an increase in cases of intoxication, with Amanita phalloides poisoning being a significant cause of death. The toxins in Amanita phalloides, mainly alpha- and beta-amanitins, exhibit hepatotoxicity and can lead to hepatocellular failure within a few days. Antioxidant antidotes are currently the most effective treatment for Amanita phalloides poisoning, highlighting the role of oxidative stress in its pathophysiology.

TOXINS (2021)

Article Immunology

Introduction to Antibody-Drug Conjugates

Mark C. Pettinato

Summary: ADCs are innovative biopharmaceutical products that combine monoclonal antibodies with small molecule drugs, primarily used in cancer treatment but with potential for other diseases. There are currently ten FDA-approved ADCs and over 90 in clinical development worldwide. The field has made significant advances in antibody discovery and formulation, but also faces challenges and requires continued innovation for future developments.

ANTIBODIES (2021)

Review Plant Sciences

Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019

David J. Newman et al.

JOURNAL OF NATURAL PRODUCTS (2020)

Review Chemistry, Medicinal

Antibody-Drug Conjugates: The Last Decade

Nicolas Joubert et al.

PHARMACEUTICALS (2020)

Review Agriculture, Multidisciplinary

Mushroom Toxins: Chemistry and Toxicology

Xia Yin et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2019)

Review Pharmacology & Pharmacy

Mushroom poisoning: A proposed new clinical classification

Julian White et al.

TOXICON (2019)

Review Public, Environmental & Occupational Health

Amatoxin-Containing Mushroom Poisonings: Species, Toxidromes, Treatments, and Outcomes

James H. Diaz

WILDERNESS & ENVIRONMENTAL MEDICINE (2018)

Review Gastroenterology & Hepatology

Drug resistance and new therapies in colorectal cancer

Kevin Van der Jeught et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2018)

Article Food Science & Technology

Pharmacokinetic Properties of the Nephrotoxin Orellanine in Rats

Deman Najar et al.

TOXINS (2018)

Article Multidisciplinary Sciences

Neanderthal behaviour, diet, and disease inferred from ancient DNA in dental calculus

Laura S. Weyrich et al.

NATURE (2017)

Article Urology & Nephrology

Long-term clinical outcome for patients poisoned by the fungal nephrotoxin orellanine

Heidi Hedman et al.

BMC NEPHROLOGY (2017)

Article Oncology

Orellanine specifically targets renal clear cell carcinoma

Lisa Buvall et al.

ONCOTARGET (2017)

Review Toxicology

Human and experimental toxicology of orellanine

Ricardo Jorge Dinis-Oliveira et al.

HUMAN & EXPERIMENTAL TOXICOLOGY (2016)

Review Biochemistry & Molecular Biology

Choosing the right cell line for renal cell cancer research

Klaudia K. Brodaczewska et al.

MOLECULAR CANCER (2016)

Article Pharmacology & Pharmacy

A novel orellanine containing mushroom Cortinarius armillatus

Dahai Shao et al.

TOXICON (2016)

Review Chemistry, Medicinal

Toward a Cancer Drug of Fungal Origin

Alexander Kornienko et al.

MEDICINAL RESEARCH REVIEWS (2015)

Article Multidisciplinary Sciences

TP53 loss creates therapeutic vulnerability in colorectal cancer

Yunhua Liu et al.

NATURE (2015)

Article Oncology

Phase II study of PX-866 in recurrent glioblastoma

Marshall W. Pitz et al.

NEURO-ONCOLOGY (2015)

Editorial Material Medicine, General & Internal

Successful living related kidney transplantation for end-stage renal failure caused by orellanine syndrome

P. Nagaraja et al.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2015)

Article Urology & Nephrology

Antioxidant treatment and outcome of cortinarius orellanus poisoning: a case series

Scott-Oliver Grebe et al.

RENAL FAILURE (2013)

Article Oncology

Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel

Michael Millward et al.

INVESTIGATIONAL NEW DRUGS (2012)

Article Plant Sciences

Analysis of the Mushroom Nephrotoxin Orellanine and Its Glucosides

Anders Herrmann et al.

JOURNAL OF NATURAL PRODUCTS (2012)

Article Plant Sciences

Endophytic fungi from medicinal plants: a treasure hunt for bioactive metabolites

Sanjana Kaul et al.

PHYTOCHEMISTRY REVIEWS (2012)

Letter Pediatrics

Fatal renal failure caused by Cortinarius mushrooms

Martin Kirchmair et al.

PEDIATRIC NEPHROLOGY (2011)

Article Biochemistry & Molecular Biology

The fungal nephrotoxin orellanine simultaneously increases oxidative stress and down-regulates cellular defenses

Ulf A. Nilsson et al.

FREE RADICAL BIOLOGY AND MEDICINE (2008)

Article History & Philosophy Of Science

Medicinal mushrooms and cancer therapy - translating a traditional practice into Western medicine

R Sullivan et al.

PERSPECTIVES IN BIOLOGY AND MEDICINE (2006)

Article Urology & Nephrology

Treatment of intoxication with Cortinarius speciosissimus using an antioxidant therapy -: art. no. e3

M Wörnle et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2004)

Review Chemistry, Organic

Synthesis of 2,2′-bipyridines:: Versatile building blocks for sexy architectures and functional nanomaterials

GR Newkome et al.

EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2004)

Article Chemistry, Multidisciplinary

Occurrence of the fungal toxin orellanine as a diglucoside and investigation of its biosynthesis

P Spiteller et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2003)

Review Biotechnology & Applied Microbiology

Medicinal mushrooms: a rapidly developing area of biotechnology for cancer therapy and other bioactivities

JE Smith et al.

BIOTECHNOLOGY LETTERS (2002)

Article Pharmacology & Pharmacy

Main features of Cortinarius spp. poisoning:: a literature review

VC Danel et al.

TOXICON (2001)

Article Toxicology

Mechanisms of toxicity, clinical features, and management of diquat poisoning: A review

GM Jones et al.

JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY (2000)